Chapter VI Dopamine systems in the primate brain

Handbook of Chemical Neuroanatomy

Volumn 13, Issue , 1997, Pages 263-375

  Lewis, D A ^a   Sesack, S R ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350662709     PISSN: 09248196     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0924-8196(97)80008-5     Document Type: Article

References (463)

1. Acheson A.L., Kapatos G., and Zigmond M.J. The effects of phosphorylating conditions on tyrosine hydroxylase activity are influenced by assay conditions and brain region. Life Sci. 28 (1981) 1407-1420
2. Adem A., Nordberg A., Jossan S.S., Sara V., and Gillberg P.G. Quantitative autoradiography of nicotinic receptors in large cryosections of human brain hemispheres. Neurosci. Lett. 101 (1989) 247-252
3. Adolfsson R., Gottfries C.G., Roos B.E., and Winblad B. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J. Neural Transm. 45 (1979) 81-105
4. submitted. Akil M., Morocco A., Edgar C., and Lewis D. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Arch. Gen. Psychiatry (1997)
5. Akil M., and Lewis D.A. The dopaminergic innervation of monkey entorhinal cortex. Cereb. Cortex 3 (1993) 533-550
6. Akil M., and Lewis D.A. The distribution of tyrosine hydroxylase-immunoreactive fibers in the human entorhinal cortex. Neuroscience 60 (1994) 857-874
7. Aldrich M.S., Hollingsworth Z., and Penney J.B. Autoradiographic studies of postmortem human narcoleptic brain. Neurophysiol. Clin. 23 (1993) 35-45
8. Amaral D.G., Veazey R.B., and Cowan W.M. Some observations on hypothalamoamygdaloid connections in the monkey. Brain Res. 252 (1982) 13-27
9. Amaral D.G., Insausti R., and Cowan W.M. The entorhinal cortex of the monkey: I. Cytoarchitectonic organization. J. Comp. Neurol. 264 (1987) 326-355
10. Amaral D.G., and Campbell M.J. Transmitter systems in the primate dentate gyrus. Hum. Neurobiol. 5 (1986) 169-180
11. Amaral D.G., and Cowan W.M. Subcortical afferents to the hippocampal formation in the monkey. J. Comp. Neurol. 189 (1980) 573-591
12. Anderson S.A., Classey J.D., Condé F., Lund J.S., and Lewis D.A. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 67 (1995) 7-22
13. Anglade P., Tsuji S., Javoy-Agid F., Agid Y., and Hirsch E.C. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease. Ann. Neurol. 37 (1995) 265-272
14. 2 mRNA and receptor levels in the striatum and nucleus accumbens of the rat. Mol. Brain Res. 11 (1991) 161-166
15. Aquilonius S.M. What has PET told us about Parkinson's disease?. Acta Neurol. Scand. Suppl. 136 (1991) 37-39
16. Arsenault M.-Y., Parent A., Seguela P., and Descarries L. Distribution and morphological characteristics of dopamine-immunoreactive neurons in the midbrain of the squirrel monkey (Saimiri sciureus). J. Comp. Neurol. 267 (1988) 489-506
17. 3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res. 486 (1989) 261-268
18. 3H]kainate. Brain Res. 658 (1994) 209-218
19. Bannon M.J., Poosch M.S., Zia Y., Goebel D.J., Cassin B., and Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc. Natl. Acad. Sci. USA 89 (1992) 7095-7099
20. Bannon M.J., and Whitty C.J. Neurokinin receptor gene expression in substantia nigra: Localization, regulation, and potential physiological significance. Can. J. Physiol. Pharmacol. 73 (1995) 866-870
21. Barbas H., Gustafson E.L., and Greengard P. Comparison of the immunocytochemical localization of DARPP-32 and I-1 in the amygdala and hippocampus of the rhesus monkey. J. Comp. Neurol. 334 (1993) 1-18
22. Beach T.G., and McGeer E.G. The distribution of substance P in the primate basal ganglia: An immunohistochemical study of baboon and human brain. Neuroscience 13 (1984) 29-52
23. Beall M.J., and Lewis D.A. Heterogeneity of layer II neurons in human entorhinal cortex. J. Comp. Neurol. 321 (1992) 241-266
24. 2 receptors in the human ventral striatum. Neurosci. Lett. 150 (1993) 75-79
25. Berger B., Verney C., Gaspar P., and Febvret A. Transient expression of tyrosine hydroxylase immunoreactivity in some neurons of the rat neocortex during postnatal development. Dev. Brain Res. 23 (1985) 141-144
26. Berger B., Trottier S., Gaspar P., Verney C., and Alvarez C. Major dopamine innervation of the cortical motor areas in the Cynomolgus monkey. A radioautographic study with comparative assessment of serotonergic afferents. Neurosci. Lett. 72 (1986) 121-127
27. Berger B., Trottier S., Verney C., Gaspar P., and Alvarez C. Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: A radioautographic study. J. Comp. Neurol. 273 (1988) 99-119
28. Berger B., Febvret A., Greengard P., and Goldman-Rakic P.S. DARPP-32, a phosphoprotein enriched in dopaminoceptive neurons bearing dopamine D1 receptors: Distribution in the cerebral cortex of the newborn and adult rhesus monkey. J. Comp. Neurol. 299 (1990) 327-348
29. Berger B., Gaspar P., and Verney C. Dopaminergic innervation of the cerebral cortex: Unexpected differences between rodents and primates. TINS 14 (1991) 21-27
30. Berger B., Verney C., and Goldman-Rakic P.S. Prenatal monaminergic innervation of the cerebral cortex: Differences between rodents and primates. In: Kostovic I., Knezevic S., Wisniewski H., and Spilich G. (Eds). Neurodevelopment, Aging and Cognition (1992), Birkhauser, New York 18-36
31. Berger B., Alvarez C., and Goldman-Rakic P.S. Neurochemical development of the hippocampal region in the fetal rhesus monkey. I. Early appearance of peptides, calcium-binding proteins, DARPP-32, and monoamine innervation in the entorhinal cortex during the first half of gestation (E47 to E90). Hippocampus 3 (1993) 279-305
32. Berger B., and Alvarez C. Neurochemical development of the hippocampal region in the fetal rhesus monkey. II. Immunocytochemistry of peptides, calcium-binding proteins, DARPP-32, and monoamine innervation in the entorhinal cortex by the end of gestation. Hippocampus 4 (1994) 85-114
33. 5 dopamine receptor: Studies in primate brain and transfected mammalian cells. Proc. Natl. Acad. Sci. USA 92 (1995) 3468-3472
34. 5 dopamine receptor in primate brain. J. Neurosci. 15 (1995) 7821-7836
35. 1 dopamine receptors in the basal ganglia of the cat and primate: Delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26 (1988) 101-119
36. Bird E.D., Spokes E., and Iversen L.L. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain 102 (1979) 347-360
37. Bjorklund A., Divac I., and Lindvall O. Regional distribution of catecholamines in monkey cerebral cortex, evidence for a dopaminergic innervation of the primate prefrontal cortex. Neurosci. Lett. 7 (1978) 115-119
38. Bogerts B. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J. Comp. Neurol. 197 (1981) 63-80
39. Bolam J.P., Francis C.M., and Henderson Z. Cholinergic input to dopaminergic neurons in the substantia nigra: A double immunocytochemical study. Neuroscience 41 (1991) 483-494
40. Bolam J.P., and Smith Y. The GABA and substance P input to dopaminergic neurons in the substantia nigra of the rat. Brain Res. 529 (1990) 57-78
41. Booze R.M., Mactutus C.F., Gutman C.R., and Davis J.N. Frequency analysis of catecholamine axonal morphology in human brain I. Effects of postmortem delay interval. J. Neurol. Sci. 119 (1993) 99-109
42. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., and Yancopoulos G.D. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF 1. Cell 65 (1991) 663-675
43. Bouyer J.J., Park D.H., Joh T.H., and Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302 (1984) 267-275
44. Braak H., and Braak E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol. 68 (1985) 325-332
45. Braak H., and Braak E. The human entorhinal cortex: Normal morphology and lamina-specific pathology in various diseases. Neurosci. Res. 15 (1992) 6-31
46. Brené S., Lindefors N., Ehrlich M., Taubes T., Horiuchi A., Kopp J., Hall H., Sedvall G., Greengard P., and Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J. Neurosci. 14 (1994) 985-998
47. 1 dopamine receptors. Neuroscience 67 (1995) 37-48
48. Brown E.R., Coker III G.T., and O'Malley K.L. Organization and evolution of the rat tyrosine hydroxylase gene. Biochemistry 26 (1987) 5208-5212
49. Brown R.M., Crane A.M., and Goldman P.S. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: Concentrations and in vivo synthesis rates. Brain Res. 168 (1979) 133-150
50. Brozoski T.J., Brown R.M., Rosvold H.E., and Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science 205 (1979) 929-932
51. Caffe A.R., Van Ryen P.C., Van der Woude T.P., and Van Leeuwen F.W. Vasopressin and oxytocin systems in the brain and upper spinal cord of Macaca fascicularis. J. Comp. Neurol. 287 (1989) 302-325
52. Campbell M.J., Lewis D.A., Foote S.L., and Morrison J.H. Distribution of choline acetyltransferase-, serotonin-, dopamine-beta-hydroxylase-, tyrosine hydroxylase-immunoreactive fibers in monkey primary auditory cortex. J. Comp. Neurol. 261 (1987) 209-220
53. 2 sites. Neuroscience 28 (1989) 275-290
54. 2 receptors in the brain of several mammalian species. J. Neural Transm. 80 (1990) 105-127
55. 3H]WIN 35,428) in the monkey brain. Synapse 6 (1996) 189-195
56. Carlsson A., and Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38 (1976) 271-276
57. Carmona A., Catalina-Herrera C.J., and Jimenez-Castellanos J. Nigrocaudate and nigroputaminal projections in the monkey. Acta Anat. 141 (1991) 145-150
58. Carpenter M., and Peter P. Nigrostriatal and nigrothalamic fibers in the rhesus monkey. J. Comp. Neurol. 144 (1972) 93-116
59. Carpenter M.B., Carleton S.C., Keller J.T., and Conte P. Connections of the subthalamic nucleus in the monkey. Brain Res. 224 (1981) 1-29
60. Carpenter M.B., and Jayaraman A. Subthalamic nucleus of the monkey: Connections and immunocytochemical features of afferents. J. Hirnforsch. 31 (1990) 653-668
61. Chan J., Aoki C., and Pickel V.M. Optimization of differential immunogold-silver and peroxidase labelling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Meth. 33 (1990) 113-127
62. Charara A., Smith Y., and Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J. Comp. Neurol. 364 (1996) 254-266
63. Charara A., and Parent A. Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey. Brain Res. 640 (1994) 155-170
64. 3H]mazindol. Neuroscience 49 (1992) 317-327
65. 5 receptor mRNAs in the monkey brain: Ribonuclease protection assay analysis. Mol. Brain Res. 31 (1995) 86-94
66. Coker III G.T., Studelska D., Harmon S., Burke W., and O'Malley K.L. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Mol. Brain Res. 8 (1990) 93-98
67. Condé F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., and Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: Distribution and morphology. J. Comp. Neurol. 341 (1994) 95-116
68. Constantinidis J., Siegried J., Frigyesi T.L., and Tissot R. Parkinson's disease and striatal dopamine: In vivo morphological evidence for the presence of dopamine in the human brain. J. Comp. Neurol. 35 (1974) 13-22
69. Cordes M., Snow B.J., Cooper S., Schulzer M., Pate B.D., Ruth T.J., and Calne D.B. Age-dependent decline of nigrostriatal dopaminergic function: A positron emission tomographic study of grandparents and their grandchildren. Ann. Neurol. 36 (1994) 667-670
70. Cortés R., Probst A., and Palacios J.M. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Brainstem. Neuroscience 12 (1984) 1003-1026
71. Cortés R., Gueye B., Pazos A., Probst A., and Palacios J.M. Dopamine receptors in human brain: Autoradiographic distribution of D(1) sites. Neuroscience 28 (1989) 263-273
72. 1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type. Brain Res. 475 (1988) 164-167
73. 2 sites in Parkinson syndrome of different etiology. Brain Res. 483 (1989) 30-38
74. Cote L.J., and Kremzner L.T. Biochemical changes in normal aging in human brain. Adv. Neurol. (1996) 19-30
75. Courtoy P.J., Picton D.H., and Farquhar M.G. Resolution and limitations of the immunoperoxidase procedure in the localization of extracellular matrix antigens. J. Histochem. Cytochem. 31 (1983) 945-951
76. D'Amato R.J., Alexander G.M., Schwartzman R.J., Kitt C.A., Price D.L., and Snyder S.H. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. Nature 327 (1987) 324-326
77. D'Mello S.R., Weisberg E.P., Stachowiak M.D., Turzai L.M., Gioio A.E., and Kaplan B.B. Isolation and nucleotide sequence of a cDNA clone encoding bovine adrenal tyrosine hydroxylase: Comparative analysis of tyrosine hydroxylase gene products. J. Neurosci. Res. 19 (1988) 440-449
78. D'Mello S.R., Turzai L.M., Gioio A.E., and Kaplan B.B. Isolation and structural characterization of the bovine tyrosine hydroxylase gene. J. Neurosci. Res. 23 (1989) 31-40
79. Dahlström A., and Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62 (1964) 1-55
80. Daniel D.G., Berman K.F., and Weinberger D.R. The effect of apomorphine on regional cerebral blood flow in schizophrenia. J. Neuropsychiatry 1 (1989) 377-384
81. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., Bigelow L.R., Goldberg T.E., Berman K.F., and Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neurosci. 11 (1991) 1907-1917
82. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiat. 148 (1991) 1474-1486
83. 3H]SCH 23390 binding sites in human prefrontal cortex (Brodmann's Area 9). J. Neurochem. 49 (1987) 789-796
84. Dearry A., Gingrich J.A., Falardeau P., Fremeau Jr. R.T., Bates M.D., and Caron M.G. Molecular cloning and expression of the gene for a human. Nature 347 (1990) 72-75
85. DeFelipe J., Hendry S.H.C., and Jones E.G. Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc. Natl. Acad. Sci. USA 86 (1989) 2093-2097
86. DeFelipe J., and Farinas I. The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs. Prog. Neurobiol. 39 (1992) 563-607
87. 3H]GBR 12935 binding to dopamine uptake sites in the human brain. J. Neurochem. 53 (1989) 1400-1404
88. DeKeyser J., Ebinger G., and Vauquelin G. Evidence for a widespread dopaminergic innervation of the human cerebral neocortex. Neurosci. Lett. 104 (1989) 281-285
89. DeKeyser J., Ebinger G., and Vauquelin G. Age-related changes in the human nigrostriatal dopaminergic system. Ann. Neurol. 27 (1990) 157-161
90. 2 dopamine receptors in the human brain: Heterogeneity based on differences in guanine nucleotide effect of agonist binding, and their presence on corticostriatal nerve terminals. Brain Res. 484 (1994) 36-42
91. Delay-Goyet P., Zajac J.M., Javoy-Agid F., Agid Y., and Roques B.P. Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects. Brain Res. 414 (1987) 8-14
92. Descarries L., and Umbriaco D. Ultrastructural basis of monoamine and acetylcholine function in CNS. Semin. Neurosci. 7 (1995) 309-318
93. Deutch A.Y., Lewis D.A., Iadarola M.J., Elsworth J.D., Redmond D.E., and Roth R.H. The effects of dopamine receptor antagonism on Fos protein expression in the striatal complex and entorhinal cortex of the non-human primate. Synapse 23 (1996) 182-191
94. Difazio M.C., Hollingsworth Z., Young A.B., and Penney Jr. J.B. Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology 42 (1992) 402-406
95. DiFiglia M., Aronin N., and Leeman S.E. Immunoreactive substance P in the substantia nigra of the monkey: Light and electron microscopic localization. Brain Res. 233 (1981) 381-388
96. DiFiglia M., Aronin N., and Martin J.B. Light and electron microscopic localization of immunoreactive leu-enkephalin in the monkey basal ganglia. J. Neurosci. 2 (1982) 303-320
97. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S.J., and Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature 378 (1995) 180-182
98. Domenech T., Beleta J., Fernandez A.G., Gristwood R.W., Cruz Sanchez F., Tolosa E., and Palacios J.M. Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: Comparison with other mammalian species. Brain Res. 21 (1994) 176-180
99. 3H] mazindol autoradiography. J. Comp. Neurol. 304 (1991) 419-434
100. Dubach M., Schmidt R., Kunkel D., Bowden D.M., Martin R., and German D.C. Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidence. Neurosci. Lett. 75 (1987) 205-210
101. Ehringer H., and Hornykiewicz O. Verteilung von Noradrenalin und Dopamin im Gehrin des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen System. Klin. Wochenschr. 38 (1960) 1236
102. Elsworth J.D., Leahy D.J., Roth R.H., and Redmond Jr. Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates. J. Neural Transm. 68 (1987) 51-62
103. Emson P.C., and Koob G.F. The origin and distribution of dopamine-containing afferents to the rat frontal cortex. Brain Res. 142 (1978) 249-267
104. Erickson S.L., Akil M., Levey A.I., and Lewis D.A. Postnatal development of the dopaminergic innervation of monkey entorhinal cortex. Soc. Neurosci. Abstr. 21 (1995) 1134
105. Falardeau P., Bedard P.J., and DiPaolo T. Relation between brain dopamine loss and D-2 dopamine receptor density in MPTP monkeys. Neurosci. Lett. 86 (1988) 225-229
106. 11C]raclopride. Arch. Gen. Psychiat. 47 (1992) 213-219
107. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., and Perry B.D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain. Res. 578 (1992) 235-243
108. Farley I.J., Price K.S., and Hornykiewicz O. Dopamine in the limbic regions of the human brain: Normal and abnormal. Adv. Biochem. Psychopharmacol. 16 (1977) 57-64
109. Fauquet M., Grima B., Lamouroux A., and Mallet J. Cloning of quail tyrosine hydroxylase: Amino acid homology with other hydroxylases discloses functional domains. J. Neurochem. 50 (1988) 142-148
110. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
111. Feger J., and Crossman A.R. Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: A retrograde fluorescence double labelling study. Neurosci. Lett. 49 (1984) 7-12
112. Feigenbaum-Langer L., and Graybiel A.M. Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res. 498 (1989) 344-350
113. Felten D.L., and Sladek J.R. Monoamine distribution in primate brain V. Monoaminergic nuclei: Anatomy, pathways and local organization. Brain Res. Bull. 10 (1983) 171-284
114. Ferrante R.J., and Kowall N.W. Tyrosine hydroxylase-like immunoreactivity is distributed in the matrix compartment of normal human and Huntington's disease striatum. Brain Res. 416 (1987) 141-146
115. 3H]forskolin binding. Exp. Neurol. 110 (1990) 219-227
116. 4 dopamine receptors in postmortem human brain. Neurosci. Lett. 175 (1994) 17-20
117. Foote S.L., and Cha C.I. Distribution of corticotropin-releasing factor-like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): An immunohistochemical study. J. Comp. Neurol. 276 (1988) 239-264
118. François C., Percheron G., Yelnik J., and Heyner S. A histological atlas of the macaque (Macaca mulatta) substantia nigra in ventricular coordinates. Brain Res. Bull. 14 (1985) 349-367
119. Freeman T.B., Spence M.S., Boss B.D., Spector D.H., Strecker R.E., Olanow C.W., and Kordower J.H. Development of dopaminergic neurons in the human substantia nigra. Exp. Neurol. 113 (1991) 344-353
120. Freund T.F., Powell J.F., and Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13 (1984) 1189-1215
121. Freund T.F., Magloczky Z., Soltesz I., and Somogyi P. Synaptic connections, axonal and dendritic patterns of neurons immunoreactive for cholecystokinin in the visual cortex of the cat. Neuroscience 19 (1986) 1133-1159
122. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol. 34 (1993) 423-431
123. Futami T., Takakusaki K., and Kitai S.T. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci. Res. 21 (1995) 331-342
124. Fuxe K., Andersson K., Schwarcz R., Agnati L.F., Pérez de la Mora M., Hökfelt T., Goldstein M., Gerland L., and Possani L. Studies on different types of dopamine nerve terminals in the forebrain and their possible interactions with neurons containing GABA, glutamate, and opioid peptides and with hormones. Adv. Neurol. 24 (1979) 199-215
125. Gaspar P., Javory-Agid F., Ploska A., and Agid Y. Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brain. J. Neurochem 34 (1980) 278-283
126. Gaspar P., Berger B., Gay M., Hamon M., Cesselin F., Vigny A., Javoy-Agid F., and Agid Y. Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. J. Neurol. Sci. 58 (1983) 247-267
127. Gaspar P., Berger B., Alvarez C., Vigny A., and Henry J.P. Catecholaminergic innervation of the septal area in man: Immunocytochemical study using TH and DBH antibodies. J. Comp. Neurol. 241 (1985) 12-33
128. Gaspar P., Berger B., Fabvret A., Vigny A., Krieger-Poulet M., and Borri-Voltattorni C. Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: A novel catecholaminergic group?. Neurosci. Lett. 80 (1987) 257-262
129. Gaspar P., Berger B., Fabvret A., Vigny A., and Henry J.P. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J. Comp. Neurol. 279 (1989) 249-271
130. Gaspar P., Berger B., and Febvret A. Neurotensin innervation of the human cerebral cortex: Lack colocalization with catecholamines. Brain Res. 530 (1990) 181-195
131. Gaspar P., Duyckaerts C., Alvarez C., Javoy-Agid F., and Berger B. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's Disease. Ann. Neurol. 30 (1991) 365-374
132. Gaspar P., Stepniewska I., and Kaas J.H. Topography and collateralization of the dopaminergic projections to motor and lateral prefrontal cortex in owl monkeys. J. Comp. Neurol. 325 (1992) 1-21
133. Gaspar P., Heizmann C.W., and Kaas J.H. Calbindin D-28K in the dopaminergic mesocortical projection of a monkey (Aotus trivirgatus). Brain Res. 603 (1993) 166-172
134. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
135. German D.C., Schlusselberg D.S., and Woodward D.J. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: From mouse to man. J. Neural Transm. 57 (1983) 243-254
136. German D.C., Manaye K., Smith W.K., Woodward D.J., and Saper C.B. Midbrain dopaminergic cell loss in Parkinson's disease: Computer visualization. Ann. Neurol. 26 (1989) 507-514
137. 28k-containing cells. Ann. NY Acad. Sci. 648 (1992) 42-62
138. Gibb W.R.G. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease. Brain Res. 581 (1992) 283-291
139. Gibb W.R.G., and Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 54 (1991) 388-396
140. Ginns E.I., Rehavi M., Martin B.M., Weller M., O'Malley K.L., LaMarca M.E., McAllister C.G., and Paul S.M. Expression of human tyrosine hydroxylase cDNA in invertebrate cells using a baculovirus vector. J. Biol. Chem. 263 (1988) 7406-7410
141. Goldman-Rakic P.S. Development of cortical circuitry and cognitive function. Child Dev. 58 (1987) 601-622
142. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., and Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. USA 86 (1989) 9015-9019
143. Goldman-Rakic P.S., Lidow M.S., and Gallager D.W. Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 10 (1990) 2125-2138
144. Goldman-Rakic P.S., Lidow M.S., Smiley J.F., and Williams M.S. The anatomy of dopamine in monkey and human prefrontal cortex. J. Neural Transm. Suppl. 36 (1992) 163-177
145. Goldman-Rakic P.S., and Brown R.M. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev. Brain Res. 4 (1982) 339-349
146. 2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus 4 (1994) 354-373
147. Goldstein M., Lieberman A., and Pearson J. Relatively high levels of dopamine in nucleus accumbens of levodopa treated patients with Parkinson's disease. J. Neural Transm. 54 (1982) 129-134
148. Goldstein M., Lieberman A.N., Helmer E., Koslow M., Ransohoff J., Elsworth J.D., Roth R.H., and Deutch A.Y. Biochemical analysis of caudate nucleus biopsy samples from Parkinsonian patients. Ann. Neurol. 24 (1988) 685-688
149. Goldstein M., and Deutch A.Y. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J. 6 (1992) 2413-2421
150. Goshima Y., Kubo T., and Misu Y. Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices. J. Neurochem. 50 (1988) 1725-1730
151. Gouras G.K., Rance N.E., Young I., and Koliatsos V.E. Tyrosine hydroxylase containing neurons in the primate basal forebrain magnocellular complex. Brain Res. 584 (1992) 287-293
152. Grafe M.R., Forno L.S., and Eng L.F. Immunocytochemical studies of substance P and met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's, and Alzheimer's diseases. J. Neuropathol. 44 (1985) 47-59
153. 1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis). Brain Res. 514 (1990) 103-110
154. Graybiel A.M. Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience 13 (1984) 1157-1187
155. Graybiel A.M., Hirsch E.C., and Agid Y.A. Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc. Natl. Acad. Sci. USA 84 (1987) 303-307
156. Graybiel A.M., and Moratalla R. Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. USA 86 (1989) 9020-9024
157. Grima B., Lamouroux A., Boni C., Julien J.-F., Javoy-Agid F., and Mallet J. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326 (1987) 707-711
158. 2 receptor density remains constant in treated Parkinson's disease. Ann. Neurol. 19 (1986) 487-492
159. Haber S.N., Lynd E., Klein C., and Groenewegen H.J. Topographic organization of the ventral striatal efferent projections in the rhesus monkey: An anterograde tracing study. J. Comp. Neurol. 293 (1990) 282-298
160. Haber S.N., Lynd-Balta E., and Mitchell S.J. The organization of the descending ventral pallidal projections in the monkey. J. Comp. Neurol. 329 (1993) 111-128
161. 2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J. Comp. Neurol. 362 (1995) 400-410
162. Haber S.N., and Groenewegen H.J. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra. J. Comp. Neurol. 290 (1989) 53-68
163. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacol. 11 (1994) 245-256
164. Halliday G.M., and Törk I. Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. J. Comp. Neurol. 252 (1991) 423-445
165. 11C]-CFT and PET in a primate model of parkinsonism. NeuroReport 3 (1992) 265-268
166. Harrington K.A., Augood S.J., Kingsbury A.E., Foster O., and Emson P.C. Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease. Mol. Brain Res. 36 (1996) 157-162
167. Haycock J.W. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem. 265 (1990) 11682-11691
168. Haycock J.W. Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40. Neurochem. Res. 18 (1993) 15-26
169. Hazrati L., Parent A., Mitchell S., and Haber S.N. Evidence for interconnections between the two segments of the globus pallidus in primates: A PHA-L anterograde tracing study. Brain Res. 533 (1990) 171-175
170. Hedreen J.C., and DeLong M.R. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J. Comp. Neurol. 304 (1991) 569-595
171. Heritch A.J. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. Schizophr. Bull. 16 (1990) 605-615
172. Herrero M.T., Hirsch E.C., Kastner A., Ruberg M., Luquin M.R., Laguna J., Javoy-Agid F., Obeso J.A., and Agid Y. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?. Neuroscience 56 (1993) 499-511
173. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648 (1994) 222-228
174. 2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch. Gen. Psychiat. 51 (1994) 116-123
175. 3H]GBR-12935 binding sites in human striatal membranes: Binding characteristics and changes in parkinsonians and schizophrenics. Japn J. Pharmacol. 47 (1988) 237-243
176. Hirsch E., Graybiel A.M., and Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 (1988) 345-348
177. 28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: Normal distribution and distribution in Parkinson's Disease. Neurodegeneration 1 (1992) 83-93
178. 3H]GBR 12923 binding site density in the prefrontal cortex of controls and schizophrenics. Biol. Psychiatry 37 (1995) 175-182
179. Hökfelt T., Fuxe K., Goldstein M., and Johansson O. Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain. Brain Res. 66 (1974) 235-251
180. Hökfelt T., Everitt B.J., Theodorsson-Norheim E., and Goldstein M. Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J. Comp. Neurol. 222 (1984) 543-559
181. Holstein G.R., Pasik P., and Hamori J. Synapses between GABA-immunoreactive axonal and dendritic elements in monkey substantia nigra. Neurosci. Lett. 66 (1986) 316-322
182. Horellou P., Le Bourdelles B., Clot-Humbert J., Guibert B., Leviel V., and Mallet J. Multiple human tyrosine hydroxylase enzymes, generated through alternative splicing, have different specific activities in Xenopus oocytes. J. Neurochem. 51 (1988) 652-655
183. Hornung J.-P., Tork I., and DeTribolet N. Morphology of tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex. Exp. Brain Res. 76 (1989) 12-20
184. Hörtnagl H., Schlögl E., Sperk G., and Hornykiewicz O. The topographical distribution of the monoaminergic innervation in the basal ganglia of the human brain. In: Changeux J.P., Glowinski J., Imbert M., and Bloom F.E. (Eds). Progress in Brain Research (1983), Elsevier, Boston 269-274
185. Huntley G.W., Morrison J.H., Prikhozhan A., and Sealfon S.C. Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum. Mol. Brain Res. 15 (1992) 181-188
186. 2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63 (1994) 357-362
187. Ibuki T., Okamura H., Miyazaki M., Yanaihara N., Zimmerman E.A., and Ibata Y. Comparative distribution of three opioid systems in the lower brainstem of the monkey (Macaca fuscata). J. Comp. Neurol. 279 (1989) 445-456
188. Ichikawa S., Ichinose H., and Nagatsu T. Multiple mRNAs of monkey tyrosine hydroxylase. Biochem. Biophys. Res. Comm. 173 (1990) 1331-1336
189. Ichikawa S., Sasaoka T., and Nagatsu T. Primary structure of mouse tyrosine hydroxylase deduced from its cDNA. Biochem. Biophys. Res. Comm. 176 (1991) 1610-1616
190. Ikemoto K., Satoh K., Maeda T., and Fibiger H.C. Neurochemical heterogeneity of the primate nucleus accumbens. Exp. Brain. Res. 104 (1995) 177-190
191. Inagaki S., Kubota Y., and Kito S. Ultrastructural localization of enkephalin immunoreactivity in the substantia nigra of the monkey. Brain Res. 362 (1986) 171-174
192. Inagaki S., and Parent A. Distribution of substance P and enkephalinlike immunoreactivity in the substantia nigra of rat, cat and monkey. Brain Res. Bull. 13 (1984) 319-329
193. Inagaki S., and Parent A. Distribution of enkephalin immunoreactive neurons in the forebrain and upper brainstem of the squirrel monkey. Brain Res. 359 (1985) 267-280
194. Innis R.B., Seibyl J.P., Scanley B.E., Laruelle M., Abi-Dargham A., Wallace E., Baldwin R.M., Zea-Ponce Y., Zoghbi S., and Wang E.A. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc. Natl. Acad. Sci. 90 (1993) 11965-11969
195. Irle E., and Markowitsch H.J. Afferent connections of the substantia innominata/basal nucleus of Meynert in carnivores and primates. J. Hirnforsch. 27 (1986) 343-367
196. Irwin I., DeLanney L.E., McNeill T., Chan P., Forno L.S., Murphy J., G.M., DiMonte D.A., Sandy M.S., and Langston J.W. Aging and the nigrostriatal dopamine system: A nonhuman primate study. Neurodegeneration 3 (1994) 251-265
197. Jaeger C.B., Ruggiero D.A., Albert V.R., Park D.M., Joh T.H., and Reis D.J. Aromatic 1-amino acid decarboxylase in the rat brain: Immunocytochemical localization in neurons of the brain stem. Neuroscience 11 (1984) 691-713
198. 3H]GBR 12395 binding to the dopamine transporter is decreased in caudate nucleus in Parkinson's disease. J. Neurochem. 49 (1987) 617-621
199. Javoy-Agid F., Ploska A., and Agid Y. Microtopography of tyrosine hydroxylase, glutamic acid decarboxylase, and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains. J. Neurochem. 37 (1981) 1218-1227
200. Jimenez-Castellanos J., and Graybiel A.M. Subdivisions of the primate substantia nigra pars compacta detected by acetylcholinesterase histochemistry. Brain Res. 437 (1987) 349-354
201. Jimenez-Castellanos J., and Graybiel A.M. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23 (1987) 223-242
202. Jimenez-Castellanos J., and Graybiel A.M. Evidence that histochemically distinct zones of the primate substantia nigra pars compacta are related to patterned distributions of nigrostriatal projection neurons and striatonigral fibers. Exp. Brain Res. 74 (1989) 227-238
203. Joh T.H., and Reis D.J. Different forms of tyrosine hydroxylase in noradrenergic and dopaminergic systems in brain. Fed. Proc. 33 (1974) 535
204. Johansen F.F., Tonder N., Zimmer J., Baimbridge K.G., and Diemer N.H. Short-term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemia. Neurosci. Lett. 120 (1990) 171-174
205. Joyce J.N., Sapp D.W., and Marshall J.F. Human striatal dopamine receptors are organized in compartments. Proc. Natl. Acad. Sci. USA 83 (1986) 8002-8006
206. 2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2 (1988) 546-557
207. 2 receptors in basal ganglia and cortex of human brain. J. Pharmacol. Exp. Therapeut. 257 (1991) 1253-1263
208. Joyce J.N. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinsons disease cases. Brain Res. 600 (1993) 156-160
209. 2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci. Lett. 154 (1993) 171-174
210. 2 receptor density. Brain Res. 382 (1996) 360-364
211. Kalsbeek A., Buijs R.M., Hofman M.A., Matthijssen M., Pool C.W., and Uylings H.B.M. Effects of neonatal thermal lesioning of the mesocortical dopaminergic projection on the development of the rat prefrontal cortex. Dev. Brain Res. 32 (1987) 123-132
212. Kalsbeek A., Matthijssen M., and Uylings H.B.M. Morphometric analysis of prefrontal and cortical development following neonatal lesioning of the dopaminergic mesocortical projection. Exp. Brain Res. 78 (1989) 279-289
213. Kaneda N., Kobayashi K., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., and Nagatsu T. Isolation of a novel cDNA clone for human tyrosine hydroxylase: Alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem. Biophys. Res. Comm. 146 (1987) 971-975
214. Kastner A., Hirsch E.C., Lejeune O., Javoy-Agid F., Rascol O., and Agid Y. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content. J. Neurochem. 59 (1992) 1080-1089
215. Kaufman M.J., and Madras B.K. Severe depletion of cocaine recognition sites associated with the dopamine transported in Parkinson's-disease striatum. Synapse 9 (1991) 43-49
216. 3H]CFT. Synapse 9 (1991) 177-187
217. 125I]epidepride. Brain Res. 609 (1993) 237-243
218. 3H-Naloxone binding to opiate receptors in the human fetal and infant brainstem. J. Comp. Neurol. 291 (1990) 55-78
219. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New Engl. J. Med. 318 (1988) 876-880
220. Kish S.J., Shannak K., Rajput A., Deck J.H., and Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 58 (1992) 642-648
221. Kitt C.A., Cork L.C., Eidelberg F., Joh T.H., and Price D.L. Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkey. Neuroscience 17 (1986) 1089-1103
222. 2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biol. Psychiat. 36 (1994) 827-835
223. Kobayashi K., Kaneda N., Ichinose H., Kishi F., Nakazawa A., Kurosawa Y., Fujita K., and Nagatsu T. Structure of the human tyrosine hydroxylase gene: Alternative splicing from a single gene accounts for generation of four mRNA types. J. Biochem. 103 (1988) 907-912
224. Kobayaski K., Kiuchi K., Ishii A., Kaneda N., Kurosawa Y., Fujita K., and Nagatsu T. Expression of four types of human tyrosine hydroxylase in COS cells. FEBS Lett. 238 (1988) 431-434
225. Komori K., Fuji T., and Nagatsu I. Do some tyrosine hydroxylase immunoreactive neurons in the human ventrolateral arcuate nucleus and globus pallidus produce only L-dopa. Neurosci. Lett. 133 (1991) 203-206
226. Kontur P.J., Al-Tikriti M., Innis R.B., and Roth R.H. Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions. J. Neurochem. 62 (1994) 282-290
227. Kosaka T., Hama K., and Nagatsu I. Tyrosine hydroxylase-immunoreactive intrinsic neurons in the rat cerebral cortex. Exp. Brain Res. 68 (1987) 393-405
228. Kostovic I., and Goldman-Rakic P.S. Transient cholinesterase staining in the mediodorsal nucleus of the thalamus and its connections in the developing human and monkey brain. J. Comp. Neurol. 219 (1983) 431-447
229. Kostovic I., and Rakic P. Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J. Comp. Neurol. 297 (1990) 441-470
230. Kowall N.W., Quigley Jr. B.J., Krause J.E., Lu F., Kosofsky B.E., and Ferrante R.J. Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regul. Peptides 46 (1993) 174-185
231. 3H]raclopride. Neurosci. Lett. 66 (1986) 85-90
232. Köhler C., Everitt B.J., Pearson J., and Goldstein M. Immunohistochemical evidence for a new group of catecholamine-containing neurons in the basal forebrain of the monkey. Neurosci. Lett. 37 (1983) 161-166
233. 2-selective ligand 125I-NCQ 298. Neurosci. Lett. 125 (1991) 12-14
234. Krayniak P.F., Meibach R.C., and Siegel A. Origin of brain stem and temporal cortical afferent fibers to the septal region in the squirrel monkey. Exp. Neurol. 72 (1981) 113-121
235. Kuljis R.O., Martin-Vasallo P., and Peress N.S. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci. Lett. 106 (1989) 49-54
236. 2-Family receptor distribution in human postmortem tissue: An autoradiographic study. NeuroReport 6 (1995) 2505-2512
237. 3 receptor mRNA and binding sites in human brain. Mol. Brain Res. 18 (1993) 187-192
238. Landwehrmeyer B., Probst A., Palacios J.M., and Mengod G. Expression of acetylcholinesterase messenger RNA in human brain: an in situ hybridization study. Neuroscience 57 (1993) 615-634
239. Langer L.F., Jimenez-Castellanos J., and Graybiel A.M. The substantia nigra and its relations with the striatum in the monkey. J. Comp. Neurol. 87 (1991) 81-99
240. Langer L.F., and Graybiel A.M. Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res. 498 (1989) 344-350
241. Lavoie B., Smith Y., and Parent A. Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry. J. Comp. Neurol. 289 (1989) 36-52
242. Lavoie B., and Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J. Comp. Neurol. 299 (1990) 1-16
243. Lavoie B., and Parent A. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. NeuroReport 2 (1991) 601-604
244. Lavoie B., and Parent A. Pedunculopontine nucleus in the squirrel monkey: Projections to the basal ganglia as revealed by anterograde tract-tracing methods. J. Comp. Neurol. 344 (1994) 210-231
245. Lavoie B., and Parent A. Pedunculopontine nucleus in the squirrel monkey: Cholinergic and glutamatergic projections to the substantia nigra. J. Comp. Neurol. 344 (1994) 232-241
246. LeBourdelles B., Boularand S., Boni C., Horellou P., Dumas S., Grima B., and Mallet J. Analysis of the 5′ region of the human tyrosine hydroxylase gene: Combinatorial patterns of exon splicing generate multiple regulated tyrosine hydroxylase isoforms. J. Neurochem. 50 (1988) 988-991
247. LeBourdelles B., Horellou P., LeCaer J., Denefle P., Latta M., Haavik J., Guibert B., Mayaux J., and Mallet J. Phosphorylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: An additional phosphorylated residue in isoform 2, generated through alternative splicing. J. Biol. Chem. 266 (1991) 17124-17130
248. Lehmann J., and Fibiger H.C. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: Properties and localization in dopaminergic neurons. J. Neurochem. 30 (1978) 615-624
249. Leichnetz G.R., and Astruc J. The efferent projections of the medial prefrontal cortex in the squirrel monkey (Saimiri sciureus). Brain Res. 109 (1976) 455-472
250. 2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci. Lett. 117 (1990) 248-252
251. LeMoine C., and Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355 (1995) 418-426
252. Lesur A., Gaspar P., Alvarez C., and Berger B. Chemoanatomic compartments in the human bed nucleus of the stria terminalis. Neuroscience 32 (1989) 181-194
253. 2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. 90 (1993) 8861-8865
254. Levitt P. Central monoamine neuron systems: Their organization in the developing and mature primate brain and the genetic regulation of their terminal fields. In: Friedhoff A.J., and Chase T.N. (Eds). Gilles de la Tourette Syndrome (1982), Raven, Amsterdam 49-59
255. Levitt P., Rakic P., and Goldman-Rakic P. Region-specific distribution of catecholamine afferents in primate cerebral cortex: A fluorescence histochemical analysis. J. Comp. Neurol. 227 (1984) 23-36
256. Levitt P., and Rakic P. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Dev. Brain Res. 4 (1982) 35-57
257. Lewis D.A., Campbell M.J., Foote S.L., Goldstein M., and Morrison J.H. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J. Neurosci. 7 (1987) 279-290
258. Lewis D.A., Foote S.L., Goldstein M., and Morrison J.H. The dopaminergic innervation of monkey prefrontal cortex: A tyrosine hydroxylase immunohistochemical study. Brain Res. 449 (1988) 225-243
259. Lewis D.A., Morrison J.H., and Goldstein M. Brainstem dopaminergic neurons project to monkey parietal cortex. Neurosci. Lett. 86 (1988) 11-16
260. Lewis D.A. The organization of chemically-identified neural systems in primate prefrontal cortex: Afferent systems. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 14 (1990) 371-377
261. Lewis D.A. Distribution of choline acetyltransferase immunoreactive axons in monkey frontal cortex. Neuroscience 40 (1991) 363-374
262. Lewis D.A., Melchitzky D.S., Gioio A., and Kaplan B.B. Neuronal localization of tyrosine hydroxylase gene products in monkey and human neocortex. Mol. Cell. Neurosci. 2 (1991) 228-234
263. Lewis D.A. The catecholaminergic innervation of primate prefrontal cortex. J. Neural Transm. 36 (1992) 179-200
264. Lewis D.A., Melchitzky D.S., and Haycock J.W. Four isoforms of tyrosine hydroxylase are expressed in human brain. Neuroscience 54 (1993) 477-492
265. Lewis D.A., Melchitzky D.S., and Haycock J.W. Expression and distribution of two isoforms of tyrosine hydroxylase in macaque monkey brain. Brain Res. 656 (1994) 1-13
266. in press. Lewis D.A., and Akil M. Cortical dopamine in schizophrenia: Strategies for postmortem studies. J. Psych. Res. (1996)
267. Lewis D.A., and Lund J.S. Heterogeneity of chandelier neurons in monkey neocortex: Corticotropin-releasing factor and parvalbumin immunoreactive populations. J. Comp. Neurol. 293 (1990) 599-615
268. Lewis D.A., and Morrison J.H. The noradrenergic innervation of monkey prefrontal cortex: A dopamine-beta-hydroxylase immunohistochemical study. J. Comp. Neurol. 282 (1989) 317-330
269. 3H]SCH23390. Brain Res. 459 (1988) 105-119
270. Lidow M.S., Goldman-Rakic P.S., Gallager D.W., Geschwind D.H., and Rakic P. Distribution of major neurotransmitter receptors in the motor and somatosensory cortex of the rhesus monkey. Neuroscience 32 (1989) 609-627
271. Lidow M.S., Goldman-Rakic P.S., Rakic P., and Innis R.B. Dopamine D(2) receptors in the cerebral cortex: Distribution and pharmacological characterization with [(3)H]raclopride. Proc. Natl. Acad. Sci. USA 86 (1989) 6412-6416
272. 3H]SCH23390. Neuroscience 40 (1991) 657-671
273. Lidow M.S., Goldman-Rakic P.S., and Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc. Natl. Acad. Sci. USA 88 (1991) 10218-10221
274. 2 dopaminergic receptors in the developing cerebral cortex of macaque monkey: A film autoradiographic study. Neuroscience 65 (1995) 439-452
275. 2-dopaminergic receptors in the primate cerebral cortex. Proc. Natl. Acad. Sci. USA 91 (1994) 4353-4356
276. Lidow M.S., and Rakic P. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb. Cortex 2 (1992) 401-416
277. Lindenamayer J.P. New pharmacotherapeutic modalities for negative symptoms in psychosis. Acta Psychiat. Scand. Suppl. 388 (1995) 15-19
278. Lindvall O., and Bjorklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. 412 (1974) 1-48
279. 3H]WIN 35428 binding sites in human striatum. Brain Res. 628 (1993) 17-25
280. 125I]RTI-121 binding sites in human striatum and medial temporal lobe. J. Pharmacol. Exp. Therapeut. 274 (1995) 1473-1483
281. 3H]GABA binding in the human brain: Alterations in Parkinson's disease. Brain Res. 127 (1977) 269-278
282. Lowenstein P.R., Joyce J.N., Coyle J.T., and Marshall J.F. Striosomal organization of cholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: A quantitative receptor autoradiographic study. Brain Res. 510 (1990) 122-126
283. Lynd-Balta E., and Haber S.N. The organization of midbrain projections to the ventral striatum in the primate. Neuroscience 59 (1994) 609-623
284. Lynd-Balta E., and Haber S.N. Primate striatonigral projections: A comparison of the sensorimotor-related striatum and the ventral striatum. J. Comp. Neurol. 345 (1994) 562-578
285. Lynd-Balta E., and Haber S.N. The organization of midbrain projections to the striatum in the primate: Sensorimotor-related striatum versus ventral striatum. Neuroscience 59 (1994) 625-640
286. MacBrown R., and Goldman P.S. Catecholamines in neocortex of rhesus monkeys: Regional distribution and ontogenetic development. Brain Res. 124 (1977) 576-580
287. Maeda T., Ikemoto K., Satoh K., Kitahama K., and Geffard M. Dopaminergic innervation of primate cerebral cortex. In: Segawa M., and Nomura Y. (Eds). Age Related Dopamine-Dependent Disorders (1995), Basel, New York 147-159
288. Mann D., and Yates P.O. Lipoprotein pigments - Their relationship to ageing in the human nervous system. Brain 97 (1974) 489-498
289. Mann D., and Yates P.O. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech. Ageing Dev. 21 (1983) 193-203
290. 3H]GBR12935 binding to dopamine uptake sites in the human brain. Brain Res. 457 (1988) 122-129
291. Marin-Padilla M., and Marin-Padilla T.M. Origin, prenatal development and structural organization of layer I of the human cerebral (motor) cortex. A Golgi study. Anat. Embryol. (Berl) 164 (1982) 161-206
292. Martin L.J., Hadfield M.G., Dellovade T.L., and Price D.L. The striatal mosaic in primates: Patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum. Neuroscience 43 (1991) 397-417
293. Mates S.L., and Lund J.S. Spine formation and maturation of type 1 synapses on spiny stellate neurons in primate visual cortex. J. Comp. Neurol. 221 (1983) 91-97
294. McGeer P.L., McGeer E.G., and Suzuki J.S. Aging and extrapyramidal function. Arch. Neurol. 34 (1977) 33-35
295. McRitchie D.A., Halliday G.M., and Cartwright H. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience 68 (1995) 539-551
296. McRitchie D.A., Hardman C.D., and Halliday G.M. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J. Comp. Neurol. 364 (1996) 121-150
297. 2 dopamine receptor mRNA in the primate brain. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 15 (1991) 885-893
298. Meador-Woodruff J.H., Damask S.P., and Watson S.J.J. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc. Natl. Acad. Sci. 91 (1994) 8297-8301
299. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H.M., Damask S.P., Little K.Y., Civelli O., and Watson Jr. S.J. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10 (1994) 239-248
300. 4 receptor expression in the human striatum. Biol. Psychiatry 38 (1995) 263-266
301. 2 receptor gene in brain. Biol. Psychiatry 30 (1991) 985-1007
302. Mehler W.R. Subcortical afferents of the amygdala in the monkey. J. Comp. Neurol. 190 (1980) 733-762
303. 1 receptor mRNA in human and rat brain. Mol. Brain Res. 10 (1991) 185-191
304. Mesulam M.M., Mash D., Hersh L., Bothwell M., and Geula C. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus. J. Comp. Neurol. 323 (1992) 252-268
305. Miyoshi R., Kito S., and Shimoyama M. Quantitative autoradiographic localization of the M1 and M2 subtypes of muscarinic acetylcholine receptors in the monkey brain. Japn J. Pharmacol. 51 (1989) 247-255
306. Mizukawa K., McGeer E.G., and McGeer P.L. Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls. Mol. Chem. Neuropathol. 18 (1993) 133-144
307. Moghaddam B., Berridge C.W., Goldman-Rakic P.S., Bunney B.S., and Roth R.H. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse 13 (1993) 215-222
308. Moghaddam B., and Bunney B.S. Acute effect of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J. Neurochem. 54 (1990) 1755-1760
309. Mons N., Tison F., and Geffard M. Identification of L-DOPA-dopamine and L-DOPA cell bodies in the rat mesencephalic dopaminergic cell systems. Synapse 4 (1989) 99-105
310. Moore R.Y. Catecholamine innervation of the basal forebrain. I. The septal area. J. Comp. Neurol. 177 (1978) 665-684
311. Moore R.Y., and Bloom F.E. Central catecholamine neuron systems: Anatomy and physiology of the dopamine systems. Annu. Rev. Neurosci. 1 (1978) 129-169
312. Mori S., Matsuura T., Takino T., and Sano Y. Light and electron microscopic immunohistochemical studies of serotonin nerve fibers in the substantia nigra of the rat, cat and monkey. Anat. Embryol. 176 (1987) 8-13
313. Morrison J.H., Foote S.L., Molliver M.E., Bloom F.E., and Lidov H.G.W. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: An immunohistochemical study. Proc. Natl. Acad. Sci. USA 79 (1982) 2401-2405
314. Morrison J.H., Foote S.L., O'Connor D., and Bloom F.E. Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: Dopamine-beta-hydroxylase immunohistochemistry. Brain Res. Bull. 9 (1982) 309-319
315. Muma N.A., Slunt H.H., and Hoffman P.N. Postnatal increases in neurofilament gene expression corrdate with the radial growth of axons. J. Neurocytol. 20 (1991) 844-854
316. 2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. USA 91 (1994) 11271-11275
317. Murray A.M., Hyde T.M., Knable M.B., Herman M.M., Bigelow L.B., Carter J.M., Weinberger D.R., and Kleinman J.E. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci. 15 (1995) 2186-2191
318. Murray A.M., Weihmueller F.B., Marshall J.F., Hurtig H.I., Gottlieb G.L., and Joyce J.N. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann. Neurol. 37 (1995) 300-312
319. Nagatsu T., Levitt M., and Udenfriend S. Tyrosine hydroxylase: The initial step in norepinephrine biosynthesis. J. Biol. Chem. 239 (1964) 2910-2917
320. Nauta H.J., and Cole M. Efferent projections of the subthalamic nucleus: An autoradiographic study in monkey and cat. J. Comp. Neurol. 180 (1978) 1-16
321. Neckameyer W.S., and Quinn W.G. Isolation and characterization of the gene for Drosophila tyrosine hydroxylase. Neuron 2 (1989) 1167-1175
322. Nitsch C., and Riesenberg R. Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection. Brain Res. 461 (1988) 127-142
323. Niznik H.B., Fogel E.F., Fassos F.F., and Seeman P. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. J. Neurochem. 56 (1991) 192-198
324. Noack H.J., and Lewis D.A. Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex. Brain Res. 500 (1989) 313-324
325. Nobin A., and Bjorklund A. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol. Scand. Suppl. 388 (1973) 3-40
326. Nomura H., Shiosaka S., and Tohyama M. Distribution of substance P-like immunoreactive structures in the brainstem of the adult human brain: An immunocytochemical study. Brain Res. 404 (1987) 365-370
327. Norita M., and Kawamura K. Subcortical afferents to the monkey amygdala: An HRP study. Brain Res. 190 (1980) 230
328. Nyberg P., Adolfsson R., Anden N.E., and Winblad B. Concentrations of dopamine and noradrenaline in some limbic and related regions of the human brain. Acta Neurol. Scand. 65 (1982) 267-273
329. O'Malley K.L., Anhalt M.J., Martin B.M., Kelsoe J.R., Winfield S.L., and Ginns E.I. Isolation and characterization of the human tyrosine hydroxylase gene: Identification of 5' alternative splice sites responsible for multiple mRNAs. Biochemistry 26 (1987) 6910-6914
330. Oeth K.M., and Lewis D.A. Cholecystokinin- and dopamine-containing mesencephalic neurons provide distinct projections to monkey prefrontal cortex. Neurosci. Lett. 145 (1992) 87-92
331. Okamura H., Kitahama K., Mons N., Ibata Y., Jouvet M., and Geffard M. L-DOPA-immunoreactive neurons in the rat hypothalamic tuberal region. Neurosci. Lett. 95 (1988) 42-46
332. Olson L., Seiger A., and Fuxe K. Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats. Brain Res. 44 (1972) 283-288
333. Olszewski J., and Baxter D. Cytoarchitecture of the Human Brainstem (1954), Karger, Karger
334. Ouimet C.C., Lamantia A.S., Goldman-Rakic P.S., Rakic P., and Greengard P. Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain. J. Comp. Neurol. 323 (1992) 209-218
335. Pakkenberg B., Moller A., Gundersen H.J.G., Mouritzen Dam A., and Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiat. 54 (1991) 30-33
336. Pakkenberg H., Andersen B.B., Burns R.S., and Pakkenberg B. A stereological study of substantia nigra in young and old rhesus monkeys. Brain Res. 693 (1995) 201-206
337. Palacios J.M., Camps M., Cortes R., and Probst A. Mapping dopamine receptors in the human brain. J. Neural Transm., (Suppl) 27 (1988) 227-235
338. Parent A., Mackey A., and De Bellefeuille L. The subcortical afferents to caudate nucleus and putamen in primate: A fluorescence retrograde double labeling study. Neuroscience 10 (1983) 1137-1150
339. Parent A., Mackey A., Smith Y., and Boucher R. The output organization of the substantia nigra in primate as revealed by a retrograde double labeling method. Brain Res. Bull. 10 (1983) 529-537
340. Parent A., Bouchard C., and Smith Y. The striatopallidal and striatonigral projections: Two distinct fiber systems in primate. Brain Res. 303 (1984) 385-390
341. Parent A., Lavoie B., Smith Y., and Bedard P. The dopaminergic nigropallidal projection in primates: Distinct cellular origin and relative sparing in MPTP-treated monkeys. Adv. Neurol. 53 (1990) 111-116
342. Parent A., and De Bellefeuille L. The pallidointralaminar and pallidonigral projections in primate as studied by retrograde double labeling method. Brain Res. 278 (1983) 11-27
343. Parent A., and Hazrati L.N. Anatomical aspects of information processing in primate basal ganglia. TINS 16 (1993) 111-116
344. Parent A., and Hazrati L.N. Multiple striatal representation in primate substantia nigra. J. Comp. Neurol. 344 (1994) 305-320
345. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20 (1995) 90-127
346. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20 (1995) 127-154
347. Parent A., and Lavoie B. Dopaminergic innervation of the basal ganglia in normal and parkinsonian monkeys. In: Schneider J.S., and Gupta M. (Eds). Current Concepts in Parkinson's Disease Research (1993), Hogrefe and Huber, Basel 403-414
348. Parent A., and Lavoie B. The heterogeneity of the mesostriatal dopaminergic system as revealed in normal and parkinsonian monkeys. Adv. Neurol. 60 (1993) 25-33
349. Parent A., and Smith Y. Differential dopaminergic innervation of the two pallidal segments in the squirrel monkey (Saimiri sciureus). Brain Res. 426 (1987) 397-400
350. Parent A., and Smith Y. Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res. 436 (1987) 296-310
351. Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21 (1987) 97-122
352. Pearson J., Goldstein M., and Brandeis L. Tyrosine hydroxylase immunohistochemistry in human brain. Brain Res. 165 (1979) 333-337
353. Pearson J., Brandeis L., and Goldstein M. Appearance of tyrosine hydroxylase immunoreactivity in the human embryo. Dev. Neurosci. 3 (1980) 140-150
354. Pearson J., Goldstein M., Markey K., and Brandeis L. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. J. Neurosci. 8 (1983) 3-32
355. Pearson J., Halliday G., Sakamoto N., and Michel J. Catecholaminergic neurons. In: Paxinos G. (Ed). The Human Nervous System (1990), Academic Press, Toronto 1023-1049
356. Pearson R.B., Woodgett J.R., Cohen P., and Kemp B.E. Substrate specificity of a multifunctional calmodulin-dependent protein kinase. J. Biol. Chem. 260 (1985) 14471-14476
357. Pickel V.M., Specht L.A., Sumal K.K., Joh T., Reis D.J., and Hervonen A. Immunocytochemical localization of tyrosine hydroxylase in the human fetal nervous system. J. Comp. Neurol. 194 (1980) 465-474
358. Pickel V.M., Beckley S.C., Joh T.H., and Reis D.J. Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum. Brain Res. 225 (1981) 373-385
359. Pcikel V.M., Chan J., and Sesack S.R. Cellular substrates for interactions between dynorphin terminals and dopaminergic dendrites in rat ventral tegmental area and substantia nigra. Brain Res. 602 (1992) 275-289
360. Pickel V.M., and Chan J. Spiny neurons lacking choline acetyltransferase immunoreactivity are major targets of cholinergic and catecholaminergic terminals in rat striatum. J. Neurosci. Res. 25 (1990) 263-280
361. Pifl C., Schingnitz G., and Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monomamines in the rhesus monkey. Neuroscience 44 (1991) 591-605
362. Pioro E.P., Hughes J.T., and Cuello A.C. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striatopallidal infarction. Brain Res. 292 (1984) 339-347
363. Plant T.M. Neuroendocrine basis of puberty in the rhesus monkey (Macaca mulatta). In: Martin L., and Ganong W.F. (Eds). Frontiers in Neuroendocrinology (1988), Raven Press, New York 215-238
364. Poirier L.J., Giguère M., and Marchand R. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res. Bull. 11 (1983) 371-397
365. Poirier L.J., and Giguere M. An autoradiographic study of the stratofugal fibers in the monkey. J. Neural Transm. Suppl. 16 (1980) 25-31
366. Porrino L.J., and Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J. Comp. Neurol. 205 (1982) 63-76
367. Price J.L., and Amaral D.G. An autoradiographic study of the projections of the central nucleus of the monkey amygdala. J. Neurosci. 1 (1981) 1242-1259
368. Qian N., and Sejnowski T.J. When is an inhibitory synapse effective?. Proc. Natl. Acad. Sci. 87 (1990) 8145-8149
369. Raisman-Vozari R., Girault J., moussaoui S., Feuerstein C., Jenner P., Marsden C., and Agid Y. Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Res. 507 (1990) 45-50
370. 5 receptor mRNAs in monkey striatum. Brain Res. 616 (1993) 242-250
371. Raynor K., Kong H., Mestek A., Bye L.S., Tian M., Liu J., Yu L., and Reisine T. Characterization of the cloned human mu opioid receptor. J. Pharmacol. Exp. Therapeut. 272 (1995) 423-428
372. Reynolds G.P. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305 (1983) 527-529
373. 4 receptors increased in schizophrenia?. J. Neurochem. 63 (1994) 1576-1577
374. 2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J. Comp. Neurol. 262 (1987) 446-463
375. Richfield E.K., Young A.B., and Penney J.B. Comparative distributions of dopamine D-1 and D-2 receptors in the cerbral cortex of rats, cats, and monkeys. J. Comp. Neurol. 286 (1989) 409-426
376. Richfield E.K., O'Brien C.F., Eskin T., and Shoulson I. Heterogeneous dopamine receptor changes in early and late Huntington's disease. Neurosci. Lett. 132 (1991) 121-126
377. 2 receptors. Brain Res. 508 (1990) 349-352
378. Rinne U.K., Lonnberg P., and Koskinen V. Dopamine receptors in the Parkinsonian brain. J. Neural Transm. 51 (1981) 97-106
379. 2 receptor supersensitivity in the striatum of patients with early Parkinson's disease. Movement Disorders 5 (1990) 55-59
380. Roberts A.C., DeSalvia M.A., Wilkinson L.S., Collins P., Muir J.L., Everitt B.J., and Robbins T.W. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: Possible interactions with subcortical dopamine. J. Neurosci. 14 (1994) 2531-2544
381. Rosenberg D.R., and Lewis D.A. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis. J. Comp. Neurol. 358 (1995) 383-400
382. Sadikot A.F., Parent A., and Francois C. Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: A PHAL study of subcortical projections. J. Comp. Neurol. 315 (1992) 137-159
383. Sadikot A.F., and Parent A. The monoaminergic innervation of the amygdala in the squirrel monkey: An immunohistochemical study. Neuroscience 36 (1990) 431-447
384. Samson Y., Wu J.J., Friedman A.H., and Davis J.N. Catecholaminergic innervation of the hippocampus in the cynomolgus monkey. J. Comp. Neurol. 298 (1990) 250-263
385. Saper C.B., and Petito C.K. Correspondence of melanin-pigmented neurons in human brain with A1-A14 catecholamine cell groups. Brain 105 (1982) 87-101
386. Sato H. Prefrontal lobe-substantia nigra projection in human cerebrum. Japn J. Psychiat. Neurol. 40 (1986) 195-207
387. Satoh K., and Matsumura H. Distribution of neurotensin-containing fibers in the frontal cortex of the macaque monkey. J. Comp. Neurol. 298 (1990) 215-223
388. Saunders R.C., Kolachana B.S., and Weinberger D.R. Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey: An in vivo microdialysis study. Exp. Brain Res. 98 (1994) 44-52
389. Sawaguchi T., Matsumura M., and Kubota K. Catecholamine sensitivities of motor cortical neurons of the monkey. Neurosci. Lett. 66 (1986) 135-140
390. Sawaguchi T., Matsumura M., and Kubota K. Dopamine modulates neuronal activities related to motor performance in the monkey prefrontal cortex. Brain Res. 371 (1986) 404-408
391. Sawle G.V., Playford E.D., Brooks D.J., Quinn N., and Frackowiak R.S.J. Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism. Brain 116 (1993) 853-867
392. Scatton B., Rouquier L., Javoy-Agid F., and Agid Y. Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 32 (1982) 1039-1040
393. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., and Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 275 (1983) 321-328
394. 3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natl. Acad. Sci. USA 90 (1993) 8942-8946
395. Schmidt R.H., and Bhatnagar R.K. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex. Brain Res. 166 (1979) 309-319
396. Schneider J.S., Yuwiler A., and Markham C.H. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res. 411 (1987) 144-150
397. Schneider J.S., and Dacko S. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. Brain Res. 556 (1991) 292-296
398. 1 receptor number - a sensitive PET marker for early brain degeneration in Huntington's disease. Eur. Arch. Psychiat. Clin. Neurosci. 243 (1994) 249-255
399. 4 receptors elevated in schizophrenia. Nature 365 (1993) 441-445
400. 4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse 14 (1993) 247-253
401. Seeman P., and Niznik H.B. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J. 4 (1990) 2737-2744
402. Seeman P., and Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15 (1994) 264-270
403. Segev I., and Rall W. Computational study of an excitable dendritic spine. J. Neurophysiol. 60 (1988) 499-523
404. Seguela P., Watkins K.C., and Descarries L. Ultrastructural features of dopamine axon terminals in the anteromedial and the suprarhinal cortex of adult rat. Brain Res 442 (1988) 11-22
405. 2 receptors in the forebrain: Cellular, regional, and species comparisons. Soc. Neurosci. Abstr. 21 (1995) 365
406. Sesack S.R., Snyder C.L., and Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J. Comp. Neurol. 363 (1995) 264-280
407. Sesack S.R., Bressler C.N., and Lewis D.A. Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex: A study of calretinin-immunoreactive cells. Neurosci. Lett. 200 (1995) 9-12
408. Sesack S.R., and Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320 (1992) 145-160
409. Sesack S.R., and Pickel V.M. Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: Multiple substrates for opiate-dopamine interactions. J. Neurosci. 12 (1992) 1335-1350
410. Sevall G. PET imaging of dopamine receptors in human basal ganglia: Relevance to mental illness. TINS 12 (1990) 302-308
411. 1 receptors in Parkinson's disease and striatonigral degeneration: A positron emission tomography study. J. Neurol. Neurosurg. Psychiat. 56 (1993) 467-472
412. Sibley D., and Monsma F. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13 (1992) 62-69
413. Smiley J.F., Williams S.M., Szigeti K., and Goldman-Rakic P.S. Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J. Comp. Neurol. 321 (1992) 325-335
414. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. USA 91 (1994) 5720-5724
415. Smiley J.F., and Goldman-Rakic P.S. Silver enhanced diaminobenzidinesulfide (SEDS): A technique for high resolution immunoelectron microscopy demonstrated with monoamine immunoreactivity in monkey cerebral cortex and caudate. J. Histochem. Cytochem. 41 (1993) 1393-1404
416. Smiley J.F., and Goldman-Rakic P.S. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: A laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb. Cortex 3 (1993) 223-238
417. Smith Y., Parent A., Seguela P., and Descarries L. Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus). J. Comp. Neurol. 259 (1987) 50-64
418. Smith Y., Lavoie B., Dumas J., and Parent A. Evidence for a distinct nigropallidal dopaminergic projection in the squirrel monkey. Brain Res. 482 (1989) 381-386
419. Smith Y., Hazrati L.N., and Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHAL anterograde tracing method. J. Comp. Neurol. 294 (1990) 306-323
420. Smith Y., Bennett B.D., Bolam J.P., Parent A., and Sadikot A.F. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J. Comp. Neurol. 344 (1994) 1-19
421. Smith Y., Charara A., and Parent A. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey. J. Comp. Neurol. 364 (1996) 231-253
422. Smith Y., and Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. TINS 13 (1990) 259-265
423. Smith Y., and Bolam J.P. The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat. J. Comp. Neurol. 296 (1990) 47-64
424. Smith Y., and Parent A. Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri sciureus). Neuroscience 18 (1986) 347-371
425. 25I]RTI-55: In vitro binding and autoradiographic characterization. J. Neurochem. 62 (1994) 549-556
426. Studler J.M., Kitabgi P., Tramu P., Herve D., Glowinksi J., and Tassin J.P. Extensive co-localization of neurotensin with dopamine in rat mesocortical-frontal dopaminergic neurons. Neuropeptides 11 (1988) 95-100
427. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res. 681 (1995) 109-116
428. Surmeier D.J., Reiner A., Levine M.S., and Ariano M.A. Are neostriatal dopamine receptors co-localized?. TINS 16 (1993) 299-305
429. Szabo J. Organization of the ascending striatal afferents in monkeys. J. Comp. Neurol. 189 (1980) 307-321
430. Tanaka C., Ishikawa M., and Shimada S. Histochemical mapping of catecholaminergic neurons and their ascending fiber pathways in the rhesus monkey brain. Brain Res. Bull. 9 (1982) 255-270
431. 1 dopaminergic binding sites in the human substantia nigra: An autoradiographic study. Neuroscience 37 (1990) 387-398
432. Torack R.M., and Morris J.C. Tyrosine hydroxylase-like (TH) immunoreactivity in human mesolimbic system. Neurosci. Lett. 116 (1990) 75-80
433. Trottier S., Geffard M., and Evrard B. Co-localization of tyrosine hydroxylase and GABA immunoreactivities in human cortical neurons. Neurosci. Lett. 106 (1989) 76-82
434. 2 receptor binding in patients with Huntington's disease and other choreas. A PET study. Brain 118 (1995) 689-696
435. Uhl G.R., Walther D., Mash D., Faucheux B., and Javoy-Agid F. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann. Neurol. 35 (1994) 494-498
436. Ulas J., Weihmuller F.B., Brunner L.C., Joyce J.M., Marshall J.F., and Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: An autoradiographic study. J. Neurosci. 14 (1994) 6317-6324
437. Van Bockstaele E.J., Cestari D.M., and Pickel V.M. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: Potential sites for modulation of mesolimbic dopamine neurons. Brain Res. 647 (1994) 307-322
438. Van Dyck C.H., Seibyl J.P., Malison R.T., Laruelle M., Wallace E., Zoghbi S.S., Zea-Ponce Y., Baldwin R.M., Charney D.S., and Hoffer P.B. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J. Nuclear Med. 36 (1995) 1175-1181
439. Van Eden C.G., Hoorneman E., Buijs R.M., Matthijssen M., Geffard M., and Uylings H.B.M. Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neuroscience 22 (1987) 849-862
440. Verney C., Zecevic N., Nikolic B., Alvarez C., and Berger B. Early evidence of catecholaminergic cell groups in 5- and 6-week-old human embryos using tyrosine hydroxylase and dopamine-β-hydroxylase immunocytochemistry. Neurosci. Lett. 131 (1991) 121-124
441. Verney C., Milosevic A., Alvarez C., and Berger B. Immunocytochemical evidence of well-developed dopaminergic and noradrenergic innervations in the frontal cerebral cortex of human fetuses at midgestation. J. Comp. Neurol. 336 (1993) 331-344
442. Vincent S.R. Distributions of tyrosine hydroxylase-, dopamine-β-hydroxylase-, and phenylethanolamine-N-methyltransferase-immunoreactive neurons in the brain of the hamster (Mesocricetus auratus). J. Comp. Neurol. 268 (1988) 584-599
443. Volkow N.D., Fowler J.S., Wang G.J., Logan J., Schlyer D., MacGregor R., Hitzemann R., and Wolf A.P. Decreased dopamine transporters with age in healthy human subjects. Ann. Neurol. 36 (1994) 237-239
444. Voorn P., Brady L.S., Schotte A., Berendse H.W., and Richfield E.K. Evidence for two neurochemical divisions in the human nucleus accumbens. Eur. J. Neurosci. 6 (1994) 1913-1916
445. Waeber C., and Palacios J.M. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: A quantitative in vitro autoradiography study. Neuroscience 32 (1989) 337-347
446. Walsh F.X., Stevens T.J., Langlais P.J., and Bird E.D. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain. Ann. Neurol. 12 (1982) 52-55
447. Walker A.E. A cytoarchitectonic study of the prefrontal area of the macaque monkey. J. Comp. Neurol. 73 (1940) 59-86
448. Wamsley J.K., Zarbin M.A., Young I., and Kuhar M.J. Distribution of opiate receptors in the monkey brain: An autoradiographic study. Neuroscience 7 (1982) 595-613
449. Waters C.M., Peck R., Rossor M., Reynolds G.P., and Hunt S.P. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Neuroscience 25 (1988) 419-438
450. Weinberger D.R. The pathogenesis of schizophrenia: A neurodevelopmental theory. In: Nasrallah H.A., and Weinberger D.R. (Eds). Handbook of Schizophrenia (1986), Elsevier Science Publishing Co. Inc., New York 397-406
451. Weinberger D.R., Berman K.F., and Illowsky B.P. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Arch. Gen. Psychiatry 45 (1988) 609-615
452. Whitehead R.E., Melchitzky D.S., Sesack S.R., Levey A.I., and Lewis D.A. Light and electron microscopic comparison of axons immunoreactive for dopamine transporter or tyrosine hydroxylase in monkey neocortex. Soc. Neurosci. Abstr. 21 (1995) 1134
453. 1 receptors in prefrontal cortex. Nature 376 (1995) 572-575
454. Williams S.M., and Goldman-Rakic P.S. Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cereb. Cortex 3 (1993) 199-222
455. Wolf M.E., LeWitt P.A., Bannon M.J., Dragovic L.J., and Kapatos G. Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate. J. Neurochem. 56 (1991) 1191-1200
456. 2 dopamine receptors in drug-naive schizophrenics. Science 234 (1986) 1558-1563
457. 11C]WIN 35,428. Synapse 15 (1993) 130-142
458. 28K. Brain Res. 526 (1990) 303-307
459. Zecevic N., Bourgeois J.P., and Rakic P. Changes in synaptic density in motor cortex of rhesus monkey during fetal and postnatal life. Dev. Brain Res. 50 (1989) 11-32
460. Zecevic N., Verney C., Milosevic A., and Berger B. First description of the central catecholamine (CA) systems in 6-8 week-old human embryos. Soc. Neurosci. Abstr. 17 (1991) 745
461. Zecevic N., and Verney C. Development of the catecholamine neurons in human embryos and fetuses, with special emphasis on the innervation of the cerebral cortex. J. Comp. Neurol. 351 (1995) 509-535
462. Zelnick N., Angel I., Paul S.M., and Kleinmann J.E. Decreased density of human striatal dopamine uptake sites with age. Eur. J. Pharmacol. 126 (1986) 175-176
463. Zhu Z., Armstrong D.L., Grossman R.G., and Hamilton W.J. Tyrosine hydroxylase-immunoreactive neurons in the temporal lobe in complex partial seizures. Ann. Neurol. 27 (1990) 564-572